Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Shijiazhuang Dingmin pharmaceutical Sciences Co.,Ltd
sales@dingminpharma.com
86-311-67260775
Modello: 1038915-60-4
marchio: DM
Appearance: Powder
Pacchetto: Doppio PE con sacchetto in alluminio
produttività: 100kg/month
Trasporti: Ocean,Air
Luogo di origine: Hebei, Cina
Supportare: 100kg/month
Certificati : ISO9001
Porta: Shanghai
Tipo di pagamento: L/C,T/T
Incoterm: FOB,CIF
Niraparib è un inibitore PARP a piccole molecole attivo per via orale sviluppato da Tesaro per trattare il carcinoma ovarico.
Il Niraparib viene utilizzato per il trattamento di mantenimento di pazienti adulti con ovarico epiteliale ricorrente, tubo di Falloppio o carcinoma peritoneale primario che sono in risposta completa o parziale alla chemioterapia a base di platino.
Test Items |
Specification |
Test Results |
Appearance |
White powder |
White powder |
Melting point |
125~127°C |
Conforms |
Specific Rotation |
+28°~+30° |
+29° |
Acidity(PH) |
5.2~6.5 |
5.8~6.2 |
Water |
4.0%~5.5% |
5.0% |
Residue On Ignition |
Not more than 0.1% |
Conforms |
N.N - dimethylaniline |
Comply with the standard |
Conforms |
Phenolic Compounds |
Comply with the standard |
Conforms |
Related Substance |
Comply with the standard |
Conforms |
Assay |
Between99.0~102.0% |
99.53% |
Conclusion |
This batch is complies with USP 41 |
Elenco prodotti : API e intermedi > Polvere di apis
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.